Harvard Apparatus Regenerative Technology, Inc. 4
4 · Harvard Apparatus Regenerative Technology, Inc. · Filed Aug 21, 2015
Insider Transaction Report
Form 4
McNaughton Thomas
Chief Financial Officer
Transactions
- Purchase
Common Stock
2015-08-19$0.62/sh+75,000$46,500→ 131,128 total - Purchase
Common Stock
2015-08-21$0.76/sh+25,000$19,000→ 156,128 total
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.59 to $0.66. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 130,023 shares of common stock held by the Reporting Person.
- [F3]This transaction was executed in multiple trades at prices ranging from $0.72 to $0.78. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Includes (a) a deferred stock award of 570 restricted stock units which vest on Jan 1, 2016; (b) a deferred stock award of 535 stock units which vest in equal installments on Jan 1, 2016 and Jan 1, 2017; and (c) 155,023 shares of common stock held by the Reporting Person.